Abstract
The use of human allograft heart valves for replacement of congenitally defective or diseased heart valves has become clinically accepted in cardiothoracic surgery. From the early days of using wet-stored “nonviable” homografts to current methods of transplanting cryogenically preserved “viable” allografts, the superiority of human heart valve implants has been well documented.1–7 However, as the clinical utilization of heart valve allografts increases, the availability of this human tissue will become a factor. With approximately 25,000 adult aortic valve replacements and 5000 pediatric reconstructions done annually in the United States,8 ways to maximize the number of heart valves available for transplant must be sought.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Khanna SK, Ross JK, Monro JL: Homograft aortic valve replacement—seven years’ experience with antibiotic-treated valves. Thorax 36: 330–337, 1981.
Wain WH, Greco R, Ignegeri A, et al: 15 Years experience with 615 homograft and autograft aortic valve replacements. Int J Artif Organs 3:169–172, 1980.
Angell WW, Angell JD, Oury JH, et al: Long-term follow-up of viable frozen aortic homografts. J Thorac Cardiovasc Surg 93: 815–822, 1987.
O’Brien MF, Stafford EG, Gardner AH, et al: A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg 94: 812–823, 1987.
O’Brien MF, personal communication, 7 March, 1988.
Kirklin JW, Blackstone EH, Maehara T, et al: Intermediate-term fate of cryopreserved allograft and xenograft valved conduits. Ann Thorac Surg 44: 598–606, 1987.
Barratt-Boyes BG, Roche AHG, Subramanyan R, et al: Long-term follow-up of the antibiotic sterilized aortic homograft valve inserted free-hand in the aortic position. Circulation 75: 768–777, 1987.
Karp RB: The use of free-hand unstented aortic valve allografts for replacement of the aortic valve. J Cardiac Surg 1: 23–32, 1986.
American Heart Association Annual Report, 1985: Dallas: AHA National Center.
The American Association of Tissue Banks: Technical Manual for Tissue Banking. Arlington, VA: AATB, 1987.
Armiger LC, Thomson RW, Striekett MG, Barratt-Boyes BG: Morphology of heart valves preserved by liquid nitrogen freezing. Thorax 40: 778–786, 1985.
Clinical Program 101—Homograft Heart Valves. Marietta, GA: Cryolife, Inc., 1985, p. 12.
Angell JD, Christopher BS, Hawtrey O, Angell WM: A fresh viable human heart valve bank— sterilization, sterility testing and cryogenic preservation. Transplant Proc 8 (suppl 1): 127–141, 1976.
Kay PH, Ross DN: 15 Years’ experience with the aortic homograft: the conduit of choice for right ventricular outflow tract reconstruction. Ann Thorac Surg 40: 360–364, 1985.
Allwork SP, Pucci JJ, Cleland WP, Bentall HH: The longevity of sterilized aortic valve homografts 1966–1972. J Cardiovasc Surg 27: 213–216, 1986.
Fontan F, Chaussat A, Deville C, et al: Aortic valve homografts in the surgical treatment of complex cardiac malformations. J Thorac Cardiovasc Surg 87: 649–657, 1984.
Barratt-Boyes GB, Roche ABG, Whitlock RML: 6 Year review of the results of freehand aortic valve replacement using an antibiotic sterilized homograft valve. Circulation 55: 353–361, 1977.
Kirklin JW, Barratt-Boyes BG: Cardiac Surgery. New York: Wiley, 1986, p. 421.
A. Schuler S, Yankah AC, Hetzer R: Allogenic valve procurement in cardiac transplantation. Cardiac Valve Allografts 1962–1987. New York: Springer-Verlag 1987, pp. 13–16.
Wolfinbarger L, Weintraub B: Technical Program Report: Heart Valve Cryopreservation. Virginia Beach, VA: Virginia Tissue Bank, 1987.
Belzer FO, Sollinger HW, Glass NR, et al: Beneficial effects of adenosine and phosphate in kidney preservation. Transplantation. 36: 633–636, 1983.
Henry ML, Sommer BG, Ferguson RM. Improved immediate function of renal allografts with Belzer perfusate. Transplantation. 45: 73–75, 1988.
Mohri H, Reichenbach DD, Merendino KA: Biology of homologous and heterologous aortic valves. In: Biological Tissue in Heart Valve Replacement. London: Butterworth, 1979, p. 144.
Ross DN, Martelli V, Wain WH: Allograft and autograft valves used for aortic valve replacement. In Ignescu MI (ed): Tissue Heart Valves. Boston: Butterworth, 1979, pp. 127–172.
Striekett MG, Barratt-Boyes BG, MacCulloch D: Disinfection of human heart valve allografts with antibiotics in low concentration. Pathology 15: 457–462, 1983.
Yacoub M, Kittle CF: Sterilization of valve homografts by antibiotic solutions. Circulation 41 (suppl): 29–31, 1970.
Lockey E, Al-Janabi N, Gonzales-Lavin L, Ross DN: A method of sterilizing and preserving fresh allograft heart valves. Thorax 27: 398–400, 1972.
Waterworth PM, Lockey E, Berry EM, Pearce HM: A critical investigation into the antibiotic sterilization of heart valve homografts. Thorax 29: 432–436, 1974.
Wain WH, Pearce HM, Riddell RW, Ross DN: A re-evaluation of antibiotic sterilization of heart valve allografts. Thorax 32: 740–742, 1977.
Gavin JB, Herdson PB, Monro JL, Barratt-Boyes BG: Pathology of antibiotic-treated human heart valve allografts. Thorax 28: 473–481, 1973.
Gavin JB, Barratt-Boyes BG, Hitchcock GC, Herdson PB: Histopathology of fresh human aortic valve allografts. Thorax 28: 482–487, 1973.
Gonzalez-Lavin L, McGrath L, Alvarez M, Graf D: Antibiotic sterilization in the preparation of homovital homograft valves: Is it necessary? Cardiac Valve Allografts 1962–1987. New York: Springer-Verlag 1987, pp. 17–21.
Girinath MR, Gavin JB, Striekett MG, Barratt-Boyes BG: The effects of antibiotics and storage on the viability and ultrastructure of fibroblasts in canine heart valves prepared for grafting. Aust NZ J Surg 44: 170, 1974.
Armiger LC, Gavin JB, Barratt-Boyes BG: Histological assessment of orthotopic aortic valve leaflet allografts: its role in selecting graft pre-treatment. Pathology 15: 67–73, 1983.
Gavin JB, Monro JL: The pathology of pulmonary and aortic valve allografts used as mitral replacements in dogs. Pathology 6: 119–127, 1974.
Watts LK, Duffy P, Field RB, et al: Establishment of a viable homograft cardiac valve bank— a rapid method of determining homograft viability. Ann Thorac Surg 21: 230–236, 1976.
Yankah AC, Hetzer R: Cardiac Valve Allografts 1962–1987. New York: Springer-Verlag, 1987, pp. 23–26.
Yankah AC, Hetzer JR: Procurement and viability of cardiac valve allografts. Cardiac Valve Allografts 1962–1987. New York: Springer-Verlag, 1987, pp. 23–26.
Kirklin JK, Kirklin JW, Pacifico JAD, Phillips S: Cryopreservation of aortic valve homografts. Cardiac Valve Allografts 1962–1987. New York: Springer-Verlag, 1987, pp. 35–36.
Gonzalez-Lavin L, Bianchi J, Graf D, Amini S, Gordon CI: Homograft valve calcification—Evidence for an immunological influence. Cardiac Valve Allografts 1962–1987. New York: Springer-Verlag, 1987, pp. 69–74.
Watkins C: University of Chicago Hospital Heart Valve Program, personal communication, October 1988.
Almeida M: American Red Cross, Los Angeles, Heart Valve Program, personal communication, October 1988.
Robbins, SL: Pathologic Basis of Disease, 3rd edition, Philadelphia: WB Saunders Co., 1984, pp. 581, 593.
Morehead, RP: Human Pathology, New York: McGraw-Hill, Inc., 1965, pp. 420–423.
McGinnis, MR: Current Topics in Medical Mycology, Volume 1, Chapter 3, New York: Springer-Verlag, 1985.
Sommerwith, AC, Jarett, L: Gradwohl’s Clinical Laboratory Methods and Diagnosis, Volume 2, 8th Edition. St. Louis: C.V. Mosby Co., 1980, p. 2205.
Bank HL, Brockbank K: Basic principles of cryobiology. J Cardiac Surg 2 (suppl): 137–143, 1987.
Ashwood-Smith MJ, Farrant J: Low Temperature Preservation in Medicine and Biology. Tunbridge Wells, Kent: Pitman, 1980, p. 12.
Karow AM, Pegg DE: Organ Preservation for Transplantation New York: Marcel Dekker, 1981, p. 480.
Bodnar E, Olsen EGJ, Florio R, et al: Heterologous antigenicity induced in human aortic homografts during preservation. Eur J Cardiothorac Surg 2: 43–47, 1988.
Yankah AC: At The First Workshop on Homologous and Autologous Heart Valves. Chicago: Deborah Heart and Lung Center, 5 April 1987.
Karow AM, Pegg DE: Organ Preservation for Transplantation New York: Marcel Dekker, 1981, p. 122.
Clinical Program 101—Homograft Heart Valves. Marietta, GA: Cryolife, Inc., August 1985, p. 17.
Mermet B, Buch W, Angell W: Viable heart valve graft—preservation in the frozen state. Surg Forum 21: 156, 1970.
VanderKamp AWM, Visser WJ, VanDongen JM, et al: Preservation of aortic heart valves with maintenance of cell viability. J Surg Res 30: 47–56, 1981.
O’Brien MF, Stafford G, Gardner M, et al: The viable cryopreserved allograft aortic valve. J Cardiac Surg 2 (suppl): 153–167, 1987.
May SR, Guttman RM, Wainwright JF: Cryopreservation of skin using an insulated heat sink box stored at —70 degrees C. Cryobiology 22: 205–214, 1985.
Grout BWW, Morris GJ: Freezing and cellular organization. In: The Effect of Low Temperatures on Biological Systems. London: Edward Arnold, 1987, pp. 147–173.
Karow AM, Pegg DE: Organ Preservation for Transplantation. New York: Marcel Dekker, 1981, p. 118.
Grout BWW, Morris GJ: The Effects of Low Temperatures on Biological Systems. London: Edward Arnold, 1987, pp. 45–46.
Mazur P: The role of cell membranes in the freezing of yeast and other single cells. Ann NY Acad Sci 125: 658, 1965.
Dowell LG, Rinfret AP: Low temperature forms of ice as studied by x-ray diffraction. Nature 188: 1144, 1960.
Ashwood-Smith MJ, Farrant J: Low Temperature Preservation in Medicine and Biology. Tunbridge Wells, Kent: Pitman, 1980, p. 291.
Luyet BJ: On various phase transitions occurring in aqueous solutions at low temperatures. Ann NY Acad Sci 85: 549, 1960.
Ashwood-Smith MJ, Farrant J: Low Temperature Preservation in Medicine and Biology. Tunbridge Wells, Kent: Pitman, 1980, p. 22.
Farrant J, Woolgar AE: Possible relationships between the physical properties of solutions and cell damage during freezing. In: The Frozen Cell. London: Churchill, 1979, p. 97.
Peterson WD, Stulbert CS: Freeze preservation of cultured animal cells. Cryobiology 1: 80, 1964.
Josylyn MA: The action of enzymes in the dried state and in concentrated solutions. In: Proceedings of the Eighth International Congress of Refrigeration. 1952, p. 331.
Watkins C: University of Chicago Hospital Heart Valve Program, personal communication, 1988.
Test Report 212: Temperature Profile. New Pague, MN: MVE Engineering, 18 February 1985.
Cryolife Inc.: U.S. Patent 4,597,266: Freezing agent and container. 1 July 1986.
Cryolife Inc.: Thermal cycling during transport of homograft tissue may compromise cell viability. Cryolife Techn Memorandum 2 (1): July 1987.
Grout BWW, Morris GJ: The Effects of Low Temperatures on Biological Systems. London: Edward Arnold, 1987, pp. 162–166.
Grout BWW, Morris GJ: The Effects of Low Temperatures on Biological Systems. London: Edward Arnold, 1987, p. 148.
Ashwood-Smith MJ, Farrant J: Low Temperature Preservation in Medicine and Biology. Tunbridge Wells, Kent: Pitman, 1980, p. 15.
O’Brien MF: (Panel Discussion #1) J Cardiac Surg 2(suppl):169, 1987.
O’Brien MF: Discussion. Cardiac Valve Allografts 1967–1987. New York: Springer-Verlag, 1987, p. 50.
American Association of Tissue Banks: Standards for Tissue Banking, Arlington, VA: AATB, 1984.
Finegold SM, Martin WJ, Scott EG: Bailey and Scott’s Diagnostic Microbiology. 5th Ed., St. Louis: Mosby, 1978.
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Lange, P.L., Hopkins, R.A. (1989). Allograft Valve Banking: Techniques and Technology. In: Cardiac Reconstructions with Allograft Valves. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3568-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3568-2_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8159-7
Online ISBN: 978-1-4612-3568-2
eBook Packages: Springer Book Archive